Last kr279.80 DKK
Change Today -1.90 / -0.67%
Volume 2.5M
As of 11:02 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mads Krogsgaard Thomsen Ph.D.

Chief Science Officer and Executive Vice President, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 3 different industries.

See Board Relationships
54kr10,400,000
As of Fiscal Year 2013

Background*

Dr. Mads Krogsgaard Thomsen, PhD serves as the Chief Science Officer and Executive Vice President at Novo Nordisk Canada Inc. Dr. Thomsen has been Chief Science Officer and Executive Vice President at Novo Nordisk A/S since November 2000. He is responsible for global research, development and regulatory affairs within Novo Nordisk. Dr. Thomsen joined Novo Nordisk in 1991 as head of Growth Hormone Research. He has been head of Growth Hormone Research, Diabetes R&D, Global ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Director
Director

Education*

Unknown/Other Education 1986
Københavns Universitet
PhD 1989
Københavns Universitet
ScD 1991
Københavns Universitet

Other Affiliations*

Annual Compensation*

Salarykr5,700,000
Bonuskr2,400,000
Total Annual Compensationkr8,100,000

Stock Options*

All Other Compensationkr2,300,000

Total Compensation*

Total Annual Cash Compensationkr10,400,000
Total Short Term Compensationkr8,100,000
Other Long Term Compensationkr2,300,000
Total Calculated Compensationkr10,400,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr279.80 DKK -1.90

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
4.4M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.